Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00186290 · ClinicalTrials.gov registry record · NA
Allo BMT in Advanced Leukemia or High Grade Lymphoma
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 145
- Enrollment target
NCT00186290: Completed NA study, sponsored by Stanford University.
NCT00186290 is a NA study that has completed, run by Stanford University. The registered enrollment target is 145 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00186290, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 145 participants
- Enrollment target
Study Summary
To evaluate the role of ablative allogeneic hematopoietic cell transplantation in the treatment of advanced leukemia or lymphoma.
Interventions
- PROCEDURE ablative allogeneic hematopoietic cell transplantation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 145 participants |
| Start Date | 1989-12 |
| Est. Completion | 2009-10 |
| Phase | NA |
What the finished NCT00186290 record still lists
NCT00186290 is an interventional study that assigns participants to a tested intervention. The registered 145 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 1 intervention - of which ablative allogeneic hematopoietic cell transplantation is the first listed.
NCT00186290 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00186290 about?
NCT00186290 is a clinical study titled "Allo BMT in Advanced Leukemia or High Grade Lymphoma". To evaluate the role of ablative allogeneic hematopoietic cell transplantation in the treatment of advanced leukemia or lymphoma.
What is the current status of trial NCT00186290?
This trial is currently completed. It is a NA study. The enrollment target is 145 participants. The study started on 1989-12. Estimated completion is 2009-10.
What interventions are being tested in trial NCT00186290?
The interventions under investigation include: ablative allogeneic hematopoietic cell transplantation (PROCEDURE).
Who is sponsoring clinical trial NCT00186290?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00186290's enrollment target sits among peer trials
145 705th of 2000 higher than 1,295 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02688959 · 145 participants · NA
Motor Attention Training for Attention Deficit Hyperactivity Disorder (ADHD)
- NCT03586609 · 145 participants · Phase 2
Venetoclax, Cladribine, Low Dose Cytarabine, and Azacitidine in Treating Patients With Previously Untreated Acute Myeloid Leukemia
- NCT03767595 · 145 participants · NA
ProACT Post-Approval Study
- NCT03808337 · 145 participants · Phase 2
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia